| January 31, 2020 |
Statin-Diabetes Link
Debate Lingers
Does it matter how long you are on statins before you worry about an increased risk of diabetes? New research not only seems to reinforce the association of increased risk of diabetes but also demonstrates that it actually may be the duration of treatment that is the real issue. Learn what researchers reported to further spark debate in an article published in Diabetes/Metabolism, Research and Reviews. |
|
|
Diabetes Diagnosis Increases Cancer Risk
Either diagnosis is a life-changing event; however, what is the impact on a diabetic patient who might need to expect a greater chance of also being diagnosed with cancer? New evidence builds on the previous understanding that patients diagnosed with diabetes are at higher risk of developing cancer, but for reasons other than what was initially hypothesized. Find out what researchers reported at the American Chemical Society Fall 2019 National Meeting & Exposition. |
|
|
Breast Cancer Drug as
New Treatment?
Currently unappreciated for its potential protective effect on beta cells from apoptosis, the MST1 inhibitor neratinib is being studied for possible repurposing as a new diabetic intervention, and researchers highlight the benefit of using pre-existing drugs to save costs in the midst of the currently escalating price of developing new drugs. Learn what researchers report as their findings in Nature Communications in November 2019. |
|
|
Connect With U.S. Pharmacist
    |
